N (% of total) | |
---|---|
Age (years) | |
< 55 | 20 (43.5%) |
> 55 | 26 (56.5%) |
Gender | |
Male | 25 (54.3%) |
Female | 21 (45.7%) |
Presentation | |
Primary | 24 (52.2%) |
Recurrent | 22 (47.8%) |
Tumor Grade | |
High | 22 (47.8%) |
Low | 24 (52.2%) |
Histologic subtype | |
Liposarcoma | 34 (73.9%) |
Leiomyosarcoma | 7 (15.2%) |
PUS | 3 (6.5%) |
Other | 2 (4.3%) |
Tumor size | |
< 5 cm | 2 (4.3%) |
5–10 cm | 7 (15.2%) |
10–20 cm | 13 (28.3%) |
> 20 cm | 24 (52.2%) |
Resection status | |
R0 | 28 (60.9%) |
R1 | 11 (23.9%) |
R2 | 7 (15.2%) |
Local resection | 18 (29.1%) |
Visceral resection | 28 (60.9%) |
Radiotherapy | |
Radiotherapy + surgery | 23 (50%) |
No radiotherapy | 23 (50%) |
Chemotherapy | |
Neoadjuvant | 2 (10.9%) |
Adjuvant | 5 (4.3%) |
Both | 1 (2.2%) |
None | 39 (84.8%) |